Delpharm
Acronym: Delpharm
General Information
Identification Code: 117047952888-72
Website: [object Object]
Entity Form: SAS
Registration Category: Companies & groups
Registration Date: 2/15/2024
EP Accredited Number: 0
Mission & Interests
Goals: Delpharm is a world leader in drug manufacturing, producing and developing the majority of existing pharmaceutical forms on behalf of international pharmaceutical companies. For over 30 years, Delpharm has built up its business by acquiring production plants from major pharmaceutical companies. In 2024, Delpharm will have 19 production plants, including 11 in France, 6,500 employees and sales of over €1,080 million. Every year, the group invests over 80 million euros in innovative solutions. Delpharm produces over 1.1 billion boxes of medicines every year.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Competition
- Energy
- Environment
- Public health
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: EU Pharmaceutical Legislation( n)EU Pharmaceutical Strategy( n)Critical Medicines Alliance( n)Electricity Market Design
Communication Activities: N/A
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Face au 9 quai du 4 Septembre
Post Code: 92100
City: Boulogne-Billancourt
Country: FRANCE
Phone: [object Object]
EU Office
Address: Face au 9 quai du 4 Septembre
Post Code: 92100
City: Boulogne-Billancourt
Country: FRANCE
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: N/A
Membership Information
Members10 Percent: 1
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.10000000149011612
Info Members: N/A
Structure
Structure Type: Structure
Is Member Of: N/A
Organisation Members: CDMO-France (https://cdmo-france.com/)
LEEM (https://www.leem.org/)